Zentel, Suspension zum Einnehmen

7680497490237 CH-49749 suspension

Associated product:

ZENTEL susp fl 10 ml
Zentel, Suspension zum Einnehmen
Zentel, Suspension zum Einnehmen
Zentel, Suspension zum Einnehmen
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
suspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AIMDK
(N/A)
- Substance AROMA
(N/A)
2.2 MG Substance HBESI
(N/A)
3.8 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance AROMA
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
4.2 MG Substance HBESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
49749
Drug name
Zentel, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
P02CA03
Authorization status
Z
Dispensing category
B
First authorization
28/12/1993
Authorization expiration date
31/12/9999
IT Number
08.05.1.
Domain
Human medicine
Field of application
Anthelminticum

Package details

Description (FR)
ZENTEL susp fl 10 ml
Description (DE)
ZENTEL Susp Fl 10 ml
Market launch
28/12/1993
Narcotic (BTM)
No